Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Acute Effects of High-intensity Interval Aerobic and Functional Training at Different Intensities

NCT07180550 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2025-10-12
Last updated
2026-03-10

Condition(s) studied

High Intensity Interval Training (Cycling)High Intensity Interval Training (Running)High Intensity Functional TrainingModerate Intensity Functional TrainingHigh Intensity Traditional Strength TrainingModerate Intensity Traditional Strength Training

Investigational drug(s) / intervention(s)

High-intensity interval training, runningHigh-intensity interval training, cyclingHigh-intensity functional trainingModerate-intensity functional trainingModerate intensity traditional strength trainingHigh intensity traditional strength training

High-intensity interval training, running: Six sets of 2-minute runs will be performed at an intensity of 90-95% of the maximal aerobic speed (MAS) on a treadmill. The recovery between each set will be 2 minutes, during which the subject will walk at an intensity of 50-60% of MAS.

High-intensity interval training, cycling: Six sets of 2-minute cycling will be performed at an intensity of 90-95% of the maximal heart rate on a stationary bike. The recovery between each set will be 2 minutes, during which the subject will cycle at an intensity of 50-60% of maximal heart rate.

High-intensity functional training: Three sets of six repetitions will be performed at 80% of the one repetition-maximum (1-RM) for six exercises. The recovery between exercises will be the minimum time required to switch from one exercise to the next, and between sets, it will be two minutes. Participants will be instructed to move the load as quickly as possible during each repetition.

Moderate-intensity functional training: Three sets of six repetitions will be performed at 60% of the 1-RM for six exercises. The recovery between exercises will be the minimum time required to switch from one exercise to the next, and between sets, it will be two minutes. Participants will be instructed to move the load as quickly as possible during each repetition.

Moderate intensity traditional strength training: Three sets of six repetitions will be performed at 60% of the 1-RM for six exercises. The recovery after each set will be two minutes of passive rest. Participants will be instructed to move the load as quickly as possible during each repetition.

High intensity traditional strength training: Three sets of six repetitions will be performed at 80% of the 1-RM for six exercises. The recovery after each set will be two minutes of passive rest. Participants will be instructed to move the load as quickly as possible during each repetition.

Study summary

Moderate-intensity physical exercise is widely recognized for its health benefits, yet time constraints limit adherence. High-intensity interval training (HIIT) has gained popularity as a more time-efficient alternative, eliciting significant cardiovascular, respiratory, metabolic, and neuromuscular responses. More recently, functional strength exercises have been integrated into high-intensity training, leading to high-intensity functional training (HIFT) and moderate-intensity functional training (MIFT). However, the acute physiological responses to these modalities remain underexplored compared to traditional HIIT (running or cycling) and strength training. This study aims to assess and compare the acute cardiovascular, metabolic, and neuromuscular responses of HIFT, MIFT, HIIT, and traditional strength training in healthy, physically active adults to inform their potential application in special populations.

Eligibility

Sex
ALL
Min age
18 Years
Max age
100 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Be 18 years of age or older. * Have at least 6 months of experience in strength training with intensities greater than 75% of one maximum repetition (1-RM). * Be classified as active according to the International Physical Activity Questionnaire (IPAQ) score. Exclusion Criteria: * Musculoskeletal injury within the 6 months prior to the first visit to the laboratory. * Recent major surgery (\<3 months). * Having a medical condition in which physical activity is contraindicated (assessed with the Physical Activity Readiness Questionnaire, PAR-Q+).

Primary outcome measure(s)

  • Heart rate variability — Week 0 (baseline), Weeks 1-4 (during intervention and 24, 48, and 72 hours post-intervention)
    The heart rate variability (HRV) of the participants will be assessed by monitoring their heart rate, which reflects the variation in the intervals between heartbeats (R-R intervals). This measure is a useful tool in monitoring patient health, as it estimates the balance between the sympathetic and parasympathetic activity of the autonomic nervous system. To evaluate heart rate variability, a Polar H10 heart rate monitor (Polar Electro Oy, Kempele, Finland) and a mobile application, specifically Elite HRV, will be used. Heart rate variability will be monitored daily during the week leading up to the initial assessment visits. Participants will be instructed to take the measurement for the first 5 minutes upon waking and while fasting. Subsequently, heart rate variability will be assessed immediately before each training condition, as well as immediately after, at 2, 24, 48, and 72 hours after finishing each training condition.

Trial sites (1)

FacilityCityRegionStatus
Miguel de Cervantes European University Valladolid Valladolid Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07180550 on ClinicalTrials.gov ↗ ← All trials in Spain